Cargando…

Advances in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: A Practical Approach to Transition Program Design: A Scientific Statement From the American Heart Association

It is now expected that most individuals with congenital heart disease will survive to adulthood, including those with complex heart conditions. Maintaining lifelong medical care requires those with congenital heart disease to eventually transfer from pediatric to adult‐oriented health care systems....

Descripción completa

Detalles Bibliográficos
Autores principales:	John, Anitha S., Jackson, Jamie L., Moons, Philip, Uzark, Karen, Mackie, Andrew S., Timmins, Susan, Lopez, Keila N., Kovacs, Adrienne H., Gurvitz, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	AHA Scientific Statement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075425/ https://www.ncbi.nlm.nih.gov/pubmed/35297271 http://dx.doi.org/10.1161/JAHA.122.025278

Ejemplares similares

Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association
por: Lopez, Keila N., et al.
Publicado: (2022)

Interstage Home Monitoring for Infants With Single Ventricle Heart Disease: Education and Management: A Scientific Statement From the American Heart Association
por: Rudd, Nancy A., et al.
Publicado: (2020)

Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease: A Scientific Statement From the American Heart Association
por: Dahdah, Nagib, et al.
Publicado: (2021)

Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association
por: Levine, Glenn N., et al.
Publicado: (2017)

Caregiver Influences on Eating Behaviors in Young Children: A Scientific Statement From the American Heart Association
por: Wood, Alexis C., et al.
Publicado: (2020)

Sleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association
por: Baker‐Smith, Carissa M., et al.
Publicado: (2021)

Clinical Implications for Exercise at Altitude Among Individuals With Cardiovascular Disease: A Scientific Statement From the American Heart Association
por: Cornwell, William K., et al.
Publicado: (2021)

Self‐Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association
por: Riegel, Barbara, et al.
Publicado: (2017)

Nonnutritive Sweeteners: Current Use and Health Perspectives: A Scientific Statement from the American Heart Association and the American Diabetes Association
por: Gardner, Christopher, et al.
Publicado: (2012)

Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association
por: de Ferranti, Sarah D., et al.
Publicado: (2014)

Empowering the Future: Transitioning to Adulthood With Congenital Heart Disease
por: Moons, Philip
Publicado: (2023)

Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes
por: Hill, James O., et al.
Publicado: (2013)

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME(®) trial
por: Fitchett, David, et al.
Publicado: (2016)

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
por: Fox, Caroline S., et al.
Publicado: (2015)

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
por: Insel, Richard A., et al.
Publicado: (2015)

Penicillin Reactions in Patients With Severe Rheumatic Heart Disease: A Presidential Advisory From the American Heart Association
por: Sanyahumbi, Amy, et al.
Publicado: (2022)

ESR statement on good scientific practice and publishing
Publicado: (2012)

Scientific Statements
Publicado: (2013)

Scientific statement on the maximum residue levels for potassium phosphonates
Publicado: (2022)

Engaging Families in Adult Cardiovascular Care: A Scientific Statement From the American Heart Association
por: Goldfarb, Michael J., et al.
Publicado: (2022)

Scientific statement on the coverage of bats by the current pesticide risk assessment for birds and mammals
por: Hernández‐Jerez, Antonio, et al.
Publicado: (2019)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016)

Developmental Care for Hospitalized Infants With Complex Congenital Heart Disease: A Science Advisory From the American Heart Association
por: Lisanti, Amy Jo, et al.
Publicado: (2023)

Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015
por: Antman, Elliott M., et al.
Publicado: (2015)

Statement on additional scientific evidence in relation to the essential composition of total diet replacement for weight control
por: Castenmiller, Jacqueline, et al.
Publicado: (2021)

Contaminant Metals as Cardiovascular Risk Factors: A Scientific Statement From the American Heart Association
por: Lamas, Gervasio A., et al.
Publicado: (2023)

The 50th Anniversary of the US Surgeon General's Report on Tobacco: What We've Accomplished and Where We Go From Here: A Presidential Advisory From the American Heart Association
por: Antman, Elliott, et al.
Publicado: (2014)

Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure: Results From the COSMIC-HF Study
por: Felker, G. Michael, et al.
Publicado: (2020)

Statement of the PPR Panel on a framework for conducting the environmental exposure and risk assessment for transition metals when used as active substances in plant protection products (PPP)
por: Hernandez‐Jerez, Antonio, et al.
Publicado: (2021)

Transition program for adolescents with congenital heart disease in transition to adulthood: protocol for a mixed-method process evaluation study (the STEPSTONES project)
por: Saarijärvi, Markus, et al.
Publicado: (2019)

International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation
por: Martinu, Tereza, et al.
Publicado: (2020)

Effects of Objective and Perceived Social Isolation on Cardiovascular and Brain Health: A Scientific Statement From the American Heart Association
por: Cené, Crystal W., et al.
Publicado: (2022)

Statement of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on the design and conduct of groundwater monitoring studies supporting groundwater exposure assessments of pesticides
por: Hernandez‐Jerez, Antonio, et al.
Publicado: (2023)

Statement on the safety of d‐ribose
por: Turck, Dominique, et al.
Publicado: (2018)

Statement on the active substance flupyradifurone
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Statement on the active substance acetamiprid
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease
por: Fratz, Sohrab, et al.
Publicado: (2013)

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods
por: Marco, Maria L., et al.
Publicado: (2021)

ESR Statement on the Validation of Imaging Biomarkers
Publicado: (2020)

ESR statement on portable ultrasound devices
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_la41kgr276c4semanm8ja5a0lr